{"id":"W2025005625","doi":"10.1016/j.beha.2013.07.007","title":"Novel oral anticoagulants in secondary prevention of stroke","year":2013,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Novartis; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Rivaroxaban; Warfarin; Dabigatran; Atrial fibrillation; Aspirin; Stroke (engine); Direct thrombin inhibitor; Phenprocoumon; Discovery and development of direct thrombin inhibitors; Internal medicine; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009990051,0.0003342652,0.004727081,0.0009776102,0.00006288516,0.00004086241,0.0003942318,0.001031637,0.0007371086],"category_scores_gemma":[0.02804,0.0002619111,0.0008678383,0.0008032907,0.0005411092,0.0004119488,0.0005742686,0.002697911,0.001137555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009509119,"about_ca_system_score_gemma":0.001594372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002360321,"about_ca_topic_score_gemma":0.00006523552,"domain_scores_codex":[0.9909497,0.003686148,0.003025103,0.0007376453,0.0009422626,0.0006590659],"domain_scores_gemma":[0.9827779,0.01424784,0.001252505,0.0008228883,0.0006502367,0.0002486572],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003014697,0.0007495987,0.0022324,0.01467737,0.0006614088,0.0003846233,0.00001267332,6.71772e-8,0.000001806755,0.00224677,0.001548533,0.9771833],"study_design_scores_gemma":[0.001736443,0.001245579,0.0003640465,0.005908223,0.001275796,0.0006254608,0.0001468875,0.00001483554,0.000001019508,0.0001155813,0.9883742,0.0001919067],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007836668,0.9822981,0.0001078459,0.001869284,0.0005917384,0.004333931,0.00002721902,0.00003135555,0.009956842],"genre_scores_gemma":[0.0001708621,0.9888861,0.004530942,0.00004740357,0.0004460915,0.00004930234,0.0001392557,0.00005641709,0.005673652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9868257,"threshold_uncertainty_score":0.9999833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6486534242812891,"score_gpt":0.6463741036705688,"score_spread":0.002279320610720337,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}